Kivel Richard 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Jun 20, 2012
Insider Transaction Report
Form 4
Kivel Richard
Director
Transactions
- Award
Stock Options (right-to-buy)
2012-06-18+20,000→ 20,000 totalExercise: $0.38Exp: 2022-06-18→ Common Stock (20,000 underlying)
Holdings
- 2,500
Common Stock
- 20,000
Stock Options (right-to-buy)
Exercise: $1.19From: 2011-09-17Exp: 2020-09-17→ Common Stock (20,000 underlying) - 20,000
Stock Options (right-to-buy)
Exercise: $1.25From: 2012-06-06Exp: 2021-06-06→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]These options vest and become exercisable in full on June 18, 2013.